Page last updated: 2024-08-16

propranolol and fk 409

propranolol has been researched along with fk 409 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hiraga, H; Okubo, T; Okumura, K; Suto, N; Yamamoto, T; Yoshida, IM1
Akimoto, Y; Horinouchi, T; Koike, K; Matsushita, M; Okamoto, T; Shibano, M; Tanaka, Y; Yamaki, F; Yamashita, Y1

Other Studies

2 other study(ies) available for propranolol and fk 409

ArticleYear
Nitric oxide donor FK409 and 8-bromoguanosine-cyclic monophosphate attenuate cardiac contractility assessed by Emax.
    Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Myocardial Contraction; Myocardium; Nitric Oxide Donors; Nitro Compounds; omega-N-Methylarginine; Papaverine; Propranolol; Vasodilation; Vasodilator Agents; Ventricular Function, Left

2001
Nitric oxide (NO) primarily accounts for endothelium-dependent component of beta-adrenoceptor-activated smooth muscle relaxation of mouse aorta in response to isoprenaline.
    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2002, Volume: 38, Issue:4-5

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta; Endothelium, Vascular; Enzyme Inhibitors; Isoproterenol; Male; Mice; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; Oxadiazoles; Propranolol; Quinoxalines; Receptors, Adrenergic, beta; Vasodilation

2002